Trans-Methyl 1-benzyl-4-p-tolylpyrrolidine-3-carboxylate
![]() |
- $496 - $589
- Product name: Trans-Methyl 1-benzyl-4-p-tolylpyrrolidine-3-carboxylate
- CAS: 898547-79-0
- MF: C20H23NO2
- MW: 309.4
- EINECS:
- MDL Number:MFCD20489350
- Synonyms:Trans-Methyl 1-benzyl-4-p-tolylpyrrolidine-3-carboxylate;(3R,4S)-Methyl 1-benzyl-4-(p-tolyl)pyrrolidine-3-carboxylate;Methyl (3R,4S)-1-benzyl-4-(p-tolyl)pyrrolidine-3-carboxylate;3-Pyrrolidinecarboxylic acid, 4-(4-methylphenyl)-1-(phenylmethyl)-, methyl ester, (3R,4S)-rel-
3 prices
Selected condition:
Brand
- Alichem
- Chemenu
- Crysdot
Package
- 1g
- ManufacturerAlichem
- Product number898547790
- Product description(3R,4S)-Methyl1-benzyl-4-(p-tolyl)pyrrolidine-3-carboxylate
- Packaging1g
- Price$567.1
- Updated2021-12-16
- Buy
- ManufacturerChemenu
- Product numberCM279113
- Product description(3R,4S)-Methyl1-benzyl-4-(p-tolyl)pyrrolidine-3-carboxylate 95%
- Packaging1g
- Price$496
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD21001190
- Product description(3R,4S)-Methyl1-benzyl-4-(p-tolyl)pyrrolidine-3-carboxylate 95+%
- Packaging1g
- Price$589
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Alichem | 898547790 | (3R,4S)-Methyl1-benzyl-4-(p-tolyl)pyrrolidine-3-carboxylate | 1g | $567.1 | 2021-12-16 | Buy |
Chemenu | CM279113 | (3R,4S)-Methyl1-benzyl-4-(p-tolyl)pyrrolidine-3-carboxylate 95% | 1g | $496 | 2021-12-16 | Buy |
Crysdot | CD21001190 | (3R,4S)-Methyl1-benzyl-4-(p-tolyl)pyrrolidine-3-carboxylate 95+% | 1g | $589 | 2021-12-16 | Buy |
Properties
Boiling point :419.3±45.0 °C(Predicted)
Density :1.120±0.06 g/cm3(Predicted)
pka :7.91±0.60(Predicted)
Density :1.120±0.06 g/cm3(Predicted)
pka :7.91±0.60(Predicted)
Safety Information
Symbol(GHS): |
![]() |
|||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Signal word: | Warning | |||||||||||||||||||||||||||||||||||
Hazard statements: |
|
|||||||||||||||||||||||||||||||||||
Precautionary statements: |
|